Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study

NCT05500001 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2025-11-18

No results posted yet for this study

Summary

Background: A lack of education, resources, and support for family carers of young adults with psychotic illnesses leaves them ill-equipped to support their loved one. Although family support groups exist, few groups offer evidence-based, skills-focused, psychoeducation taught by certified professionals and provided on a public-health level. By equipping families with skills and knowledge, public healthcare harnesses a powerful ally to maintain community stabilization.

Aims: The primary study goal is to implement a psychoeducation intervention for family carers supporting young adults with psychosis to reduce family burden and foster community stabilization of service users.

Methods: A longitudinal pre-post design will be used to assess the long-term effectiveness of the psychoeducation intervention for family carers supporting a young adult with psychosis on service utilization and functional indexes. Nine expert-reviewed, and family peer-informed psychoeducation modules are administered in 2-hour sessions over 9 weeks to family carers.

Conclusion: Presenting the novel approach of an expert-reviewed, peer-informed psychoeducation intervention for family carers, with a focus on knowledge and skill development, the researchers contribute to literature and best practice in patient and family-centered care.

Conditions

  • Psychotic Disorders
  • Family Members
  • Anosognosia
  • Paranoia

Interventions

BEHAVIORAL

Supporting Patients by Family Education in Psychotic Illness Group

Psychoeducation for families supporting young adults with psychosis.

Sponsors & Collaborators

  • Alberta Health services

    collaborator OTHER
  • Families Supporting Adults with Mental Illness-Alberta

    collaborator UNKNOWN
  • University of Alberta

    lead OTHER

Principal Investigators

  • Melanie Robles, md · University of Alberta

  • Adam Abba-Aji, MD · Alberta Health services

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
17 Years
Max Age
27 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2026-09-01
Completion
2026-09-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05500001 on ClinicalTrials.gov